A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
Eli Lilly and Company
Eli Lilly and Company
Nammi Therapeutics Inc
National Cancer Institute (NCI)
Exscientia AI Limited
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Zumutor Biologics Inc.
Agenus Inc.
National Cancer Institute (NCI)
Orano Med LLC
ViroMissile, Inc.
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Oscotec Inc.
Phrontline Biopharma
Innate Pharma
NeoTX Therapeutics Ltd.
Hangzhou DAC Biotechnology Co., Ltd.
Jonsson Comprehensive Cancer Center
Novita Pharmaceuticals, Inc.
NextPoint Therapeutics, Inc.
Columbia University
Theratechnologies
Oxford Vacmedix UK Ltd.
National Cancer Institute (NCI)
Carisma Therapeutics Inc
Astellas Pharma Inc
Eli Lilly and Company
Vincerx Pharma, Inc.
NGM Biopharmaceuticals, Inc
Pfizer
NGM Biopharmaceuticals, Inc
Pfizer
Prelude Therapeutics
Lebanese University
Canadian Cancer Trials Group
AvenCell Therapeutics, Inc.
AstraZeneca
Xencor, Inc.
Mirati Therapeutics Inc.
Quadriga Biosciences, Inc.
Xencor, Inc.
Ludwig Institute for Cancer Research
PACT Pharma, Inc.
Imperial College London
NRG Oncology
MacroGenics
MacroGenics